Top Page
Fiji Kava Limited
(Sydney:CCO)
Fiji Kava Limited (CCO) vs. iShares MSCI Australia ETF (EWA)
Fiji Kava Limited Business Overview & Revenue Model
Fiji Kava Limited Financial Statement Overview
| Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.26M | 1.78M | 2.08M | 1.16M | 758.87K |
| Gross Profit | 2.05M | -1.40M | 665.97K | 404.43K | 184.33K |
| EBITDA | -3.34M | -4.86M | -5.72M | -3.19M | -3.56M |
| Net Income | -3.73M | -5.24M | -5.46M | -3.39M | -3.81M |
Balance Sheet | |||||
| Total Assets | 4.33M | 3.24M | 4.79M | 3.60M | 2.95M |
| Cash, Cash Equivalents and Short-Term Investments | 1.10M | 462.15K | 799.22K | 1.18M | 1.43M |
| Total Debt | 2.21M | 2.35M | 1.08M | 125.00K | 750.38K |
| Total Liabilities | 4.80M | 3.32M | 2.51M | 694.78K | 1.56M |
| Stockholders Equity | -466.84K | -87.53K | 2.28M | 2.91M | 1.38M |
Cash Flow | |||||
| Free Cash Flow | -2.19M | -3.82M | -7.10M | -4.40M | -3.67M |
| Operating Cash Flow | -2.08M | -3.80M | -6.14M | -4.14M | -3.54M |
| Investing Cash Flow | -116.97K | -21.08K | -964.94K | -259.37K | -135.57K |
| Financing Cash Flow | 2.83M | 3.47M | 6.03M | 4.16M | 2.79M |
Fiji Kava Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $26.91B | 15.40 | -4.43% | 2.85% | 1.05% | 4.97% | |
42 Neutral | AU$5.10M | ― | -76.28% | ― | 5.01% | 74.84% | |
36 Underperform | AU$9.03M | ― | -548.03% | ― | 192.34% | 68.06% | |
| ― | €2.88M | ― | ― | ― | ― | ||
34 Underperform | AU$8.86M | ― | -105.17% | ― | -3.82% | 51.47% | |
| ― | AU$5.99M | ― | ― | ― | ― | ||
31 Underperform | AU$4.23M | ― | ― | -16.29% | 58.77% |
Fiji Kava Limited Corporate Events
The Calmer Co International Limited has announced a change in the director’s interest, specifically involving John Homewood. Mr. Homewood, through his associations with Homewood Venture Capital Pty Ltd and Ace Property Holdings Pty Ltd, has increased his holdings of Fully Paid Ordinary Shares (FPOS) by acquiring 13,527,825 shares, bringing the total to 133,527,825 FPOS. This acquisition was made through an on-market trade at a value of $0.003 per share. The change in Mr. Homewood’s interest could potentially impact the company’s market perception and stakeholder confidence, as it reflects a significant increase in his investment in the company.
The Calmer Co. International Limited has achieved a significant milestone with its FY25 revenue surpassing AU$8 million, marking an 86% increase from the previous year. This growth is attributed to a strong multichannel strategy and the successful expansion of its product offerings, including the launch of new flavoured Taki Mai Kava Shots on Amazon USA. The company’s strategic focus on the US market is further supported by increasing brand share and customer loyalty on Amazon, as well as partnerships to enter the US kava bar market, positioning it for continued growth and market leadership.
The Calmer Co. International Limited is capitalizing on the global demand for natural relaxation and sleep aids by expanding its product offerings and distribution channels. The company’s commitment to a transparent supply chain and its strategic partnerships in key markets are expected to enhance its market position and provide growth opportunities. This expansion is likely to have a positive impact on its operations and strengthen its industry standing.
The Calmer Co. has launched its Taki Mai kava tinctures on Amazon USA, marking a significant step in its expansion into the U.S. market. These tinctures, available in 1oz and 4oz bottles, are designed for modern wellness consumers and can be used directly or mixed into beverages. The launch positions The Calmer Co. as a leader in the growing kava category, with the Amazon tincture market valued at over US$11.16 million and growing at 18% annually. The company anticipates significant revenue growth from the U.S. market, which currently contributes 29% of its revenue, and aims to capitalize on the increasing demand for kava products.
The Calmer Co. International Limited has announced the launch of its Fiji Kava® 50g Instant Kava product in Woolworths supermarkets across Australia, excluding the Northern Territory. This expansion into Woolworths, Australia’s largest supermarket chain, builds on the company’s existing presence in Coles and reinforces its leadership in the functional relaxation and natural alternatives to alcohol category. The move is a significant step in The Calmer Co’s omnichannel growth strategy, which aims to expand its reach across Australia, the USA, and the Pacific Islands, highlighting strong consumer demand for kava-based solutions.
The Calmer Co International Limited has issued 37,500 fully paid ordinary shares following the exercise of options, as per the Corporations Act 2001. This move, authorized by the company’s Board of Directors, reflects compliance with relevant legal provisions and indicates no excluded information is required to be disclosed. This issuance could impact the company’s financial structure and stakeholder interests.
The Calmer Co. International Limited has announced a significant expansion in the distribution of its flagship kava products, Taki Mai Kava-shot and FijiKava Instant Kava, in Coles Supermarkets across Australia. The Taki Mai Kava-shot is now available in 797 stores, and the FijiKava Instant Kava is in 801 stores, reflecting a 59% and 170% increase in store coverage, respectively. This expansion is driven by the growing consumer demand for natural wellness products that offer functional alternatives to alcohol. The company views this growth as a validation of its strategy and leadership in the kava market, further strengthening its brand presence in the Australian retail channel.
The Calmer Co International Limited has announced a change in the director’s interest notice, specifically regarding John Homewood. Homewood Venture Capital Pty Ltd and Ace Property Holdings Pty Ltd, both associated with Mr. Homewood, have increased their holdings in the company through the acquisition of additional fully paid ordinary shares and options. This change reflects an allocation of shares and options pursuant to a rights offer, potentially impacting the company’s market positioning by increasing insider holdings.
The Calmer Co International Limited has announced the quotation of new securities on the Australian Securities Exchange (ASX). The company will be quoting 75,666,667 ordinary fully paid shares and 37,833,335 options expiring on June 30, 2026. This move is part of previously announced transactions and may impact the company’s market presence by potentially increasing liquidity and investor interest.
The Calmer Co. International Limited has successfully completed its renounceable rights issue, raising $1,000,713 before costs. This capital will be allocated towards capital expenditure, inventory expansion, marketing, brand promotion, and general working capital. The company’s directors and management have shown strong commitment by participating in the rights issue, reflecting confidence in the company’s future. The issuance of new shares and options is scheduled for May 16, 2025, with Mahe Capital Pty Ltd acting as the lead manager and underwriter.
The Calmer Co. International Limited reported a significant 104% year-on-year increase in its USA Amazon sales for April 2025, reaching AUD$203,000. This growth is attributed to the strong performance of its Taki Mai traditional kava brand, which accounted for 24% of the sales, and a notable rise in subscription sales, making up 28% of the total sales volume. The company is strategically expanding its presence in the U.S. market by focusing on both its instant kava brand, Fiji Kava, and its heritage brand, Taki Mai, to capture different market segments. This expansion is part of a broader strategy to launch new products and invest in R&D for long-term success.
The Calmer Co. International Limited has signed a non-binding Memorandum of Understanding with Leilo, a leading US functional beverage company, to supply high-grade noble kava powders from the South Pacific to US kava bars. This partnership aims to expand The Calmer Co.’s presence in the North American market, leveraging its expertise in kava supply and supporting the growing demand for non-alcoholic beverages. The collaboration is expected to enhance the company’s market positioning and provide a stable supply chain for Leilo’s kava bar partners, potentially leading to a formal long-term supply agreement.
The global kava root extract market is projected to grow significantly, reaching USD 5.6 billion by 2033, driven by the food and beverage industry’s growth, increased use in cosmetics and personal care, and extensive R&D activities. This growth presents opportunities for Fiji Kava Limited to enhance its market positioning and expand its operations, benefiting stakeholders by tapping into the rising demand for natural relaxation products.